Cargando…

Current Molecular Targeted Agents for Advanced Gastric Cancer

Gastric cancer is the third leading cause of malignant tumor-related mortality worldwide. Traditional cytotoxic agents prolong the overall survival and progression-free survival of patients with advanced gastric cancer (AGC) compared to that with best supportive care. Due to the occurrence of seriou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Shanshan, Yang, Guoping, Lu, Hongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229784/ https://www.ncbi.nlm.nih.gov/pubmed/32494161 http://dx.doi.org/10.2147/OTT.S246412

Ejemplares similares

Molecular targeted therapy for advanced gastric cancer
por: Kim, Jong Gwang
Publicado: (2013)

Biomarkers of gastric cancer: current advancement
por: Jiang, Tiantian, et al.
Publicado: (2022)

Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
por: Yoshinami, Yuri, et al.
Publicado: (2023)

Novel targeted agents for gastric cancer
por: Liu, Lian, et al.
Publicado: (2012)

Molecular targeted therapy for the treatment of gastric cancer
por: Xu, Wenting, et al.
Publicado: (2016)

Molecular Targeted Agents for Gastric Cancer: A Step Forward Towards Personalized Therapy
por: Cidon, Esther Una, et al.
Publicado: (2013)

Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications
por: Lim, Hui Jun, et al.
Publicado: (2023)

Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application
por: Li, Kaichun, et al.
Publicado: (2016)

Advance of Molecular Imaging Technology and Targeted Imaging Agent in Imaging and Therapy
por: Chen, Zhi-Yi, et al.
Publicado: (2014)

The Current State of Targeted Agents in Rectal Cancer
por: Kim, Dae Dong, et al.
Publicado: (2012)

Early Gastric Cancer: Current Advances of Endoscopic Diagnosis and Treatment
por: Zhu, Linlin, et al.
Publicado: (2016)

Chemotherapy for Advanced Gastric Cancer: Review and Update of Current Practices
por: Park, Sung Chul, et al.
Publicado: (2013)

The progress of targeted therapy in advanced gastric cancer
por: Qiu, Miao-zhen, et al.
Publicado: (2013)

Targeted and novel therapy in advanced gastric cancer
por: Selim, Julie H., et al.
Publicado: (2019)

Molecular target: pan-AKT in gastric cancer
por: Kang, Byung Woog, et al.
Publicado: (2020)

Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer
por: Stolfi, Carmine, et al.
Publicado: (2012)

A pooled analysis of molecularly targeted agents for treatment of metastatic oesophago-gastric cancer in elderly patients
por: Lv, Hui, et al.
Publicado: (2020)

Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment
por: Polireddy, Kishore, et al.
Publicado: (2016)

Treatment-related severe and fatal adverse events with molecular targeted agents in the treatment of advanced gastric cancer: a meta-analysis
por: Wang, Liang, et al.
Publicado: (2017)

Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
por: Wilkes, Gail M.
Publicado: (2018)

Stroÿma-Directed Molecular Targeted Therapy in Gastric Cancer
por: Kitadai, Yasuhiko, et al.
Publicado: (2011)

Current status of extended ‘D2 plus’ lymphadenectomy in advanced gastric cancer
por: Li, Jing-Quan, et al.
Publicado: (2021)

Laparoscopic Surgery for Advanced Gastric Cancer: Current Status and Future Perspectives
por: Uyama, Ichiro, et al.
Publicado: (2013)

Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives
por: Yong, Jiaxin, et al.
Publicado: (2021)

Molecularly Targeted Agents as Radiosensitizers in Cancer Therapy—Focus on Prostate Cancer
por: Alcorn, Sara, et al.
Publicado: (2013)

Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers
por: Suyama, Koichi, et al.
Publicado: (2018)

Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances
por: Ganzleben, Ingo, et al.
Publicado: (2021)

Current advances of liquid biopsies in prostate cancer: Molecular biomarkers
por: Alahdal, Murad, et al.
Publicado: (2023)

Recent advances in targeted protein degraders as potential therapeutic agents
por: Yang, Na, et al.
Publicado: (2023)

Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity
por: Yang, Xiao-Guang, et al.
Publicado: (2019)

Cytokine-Based Immunotherapy for Advanced Kidney Cancer: Past Results and Future Perspectives in the Era of Molecularly Targeted Agents
por: Porta, Camillo, et al.
Publicado: (2007)

Gastric Accumulation of Bone Seeking Agent in a Patient with Advanced Gastric Cancer
por: Kim, Dae-Weung, et al.
Publicado: (2007)

Molecular Diagnosis for Personalized Target Therapy in Gastric Cancer
por: Cho, Jae Yong
Publicado: (2013)

Molecularly Targeted Therapies for Gastric Cancer. State of the Art
por: Reddavid, Rossella, et al.
Publicado: (2021)

Ion channels or aquaporins as novel molecular targets in gastric cancer
por: Xia, Jianling, et al.
Publicado: (2017)

Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
por: Zhu, Zhi, et al.
Publicado: (2020)

Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives
por: Tokunaga, Masanori, et al.
Publicado: (2019)

Current status and perspectives of conversion therapy for advanced gastric cancer
por: Yang, Heli, et al.
Publicado: (2022)

Gastric Cancer Stem Cells: Current Insights into the Immune Microenvironment and Therapeutic Targets
por: Fu, Lingfeng, et al.
Publicado: (2020)

History and Future of HER2-Targeted Therapy for Advanced Gastric Cancer
por: Ariga, Shin
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p0kvaf7tefpunncik6r6849qem